FAVALLI, ENNIO GIULIO

FAVALLI, ENNIO GIULIO  

Dipartimento di Scienze Cliniche e di Comunità  

Mostra records
Risultati 1 - 20 di 133 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registry 2024 Favalli E. G.Caporali R. + Article (author) -
Tight control in patients with rheumatoid arthritis treated with targeted therapies across the COVID-19 pandemic era 2023 Cincinelli, GilbertoOrenti, AnnalisaBoracchi, PatriziaFavalli, Ennio GiulioCaporali, RobertoIngegnoli, Francesca + Article (author) -
The impact of EMA recommendations on the real-life use of Janus kinases inhibitors for rheumatoid arthritis: the Expanded Risk Score in RA as a tool to quantify the risk of cardiovascular events 2023 Favalli E. G.Cincinelli G.Germinario S.Di Taranto R.Orsini F.Maioli G.Biggioggero M.Ferrito M.Caporali R. Article (author) -
Rheumatoid Arthritis from Easy to Complex Disease: From the “2022 GISEA International Symposium” 2023 Caporali R.Favalli E. G. + Article (author) -
From Bench to Bedside in Rheumatoid Arthritis from the “2022 GISEA International Symposium” 2023 Caporali R.Favalli E. G. + Article (author) -
Effect of neridronate on axial involvement in patients with spondyloarthritis when biologics are not possible. Results of a monocentric study 2023 Crotti C.Di Taranto R.Orsini F.Ferrito M.Favalli E. G.Caporali R. + Article (author) -
Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission 2023 Giacomelli, RobertoCaporali, RobertoBrucato, AntonioUrsini, FrancescoFavalli, Ennio + Article (author) -
Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients 2023 M. FerritoG. CincinelliR. Di TarantoE. G. FavalliR. Caporali + Article (author) -
One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment 2023 Favalli E. G. + Article (author) -
Lessons learned from the preclinical discovery and development of sarilumab for the treatment of rheumatoid arthritis 2022 Gabriella MaioliRoberto CaporaliEnnio Giulio Favalli Article (author) -
The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study 2022 Favalli, Ennio GiulioMaioli, GabriellaBiggioggero, MartinaPesce, ElisaMartinovic, MartinaGori, AndreaAbrignani, SergioCaporali, Roberto + Article (author) -
Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine 2022 Favalli E. G.Cornalba M.Caporali R. + Article (author) -
Certolizumab Pegol Treatment in Patients with Axial-Spondyloarthritis-Associated Acute Anterior Uveitis: a Narrative Review 2022 Favalli E. G. + Article (author) -
Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium” 2022 Favalli E. G.Caporali R. + Article (author) -
Secukinumab efficacy in patients with PsA is not dependent on patients' body mass index 2022 Favalli E. G. + Article (author) -
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium 2022 Favalli E. G.Caporali R. + Article (author) -
Real-world 6 and 12-month drug retention, remission and response rates of secukinumab in 2,017 psoriatic arthritis patients in 13 European countries 2022 Favalli, Ennio G + Article (author) -
Inflammatory correlates of the Patient Global Assessment of Disease Activity vary in relation to disease duration and autoantibody status in patients with rheumatoid arthritis 2022 Favalli E. G.Caporali R. + Article (author) -
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations 2022 Favalli, Ennio GiulioZagato, ElenaMaioli, GabriellaPesce, ElisaDonnici, LorenaBiggioggero, MartinaCurti, SerenaManganaro, LaraBevilacqua, ValeriaMartinovic, MartinaMarongiu, LauraNotarbartolo, SamueleBandera, AlessandraGori, AndreaDe Francesco, RaffaeleAbrignani, SergioCaporali, Roberto + Article (author) -
Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insights 2021 Raimondo M. G.Biggioggero M.Coletto L. A.Caporali R.Favalli E. G. + Article (author) -